[G6PD deficiency in a western area of Genoa. Genetic study of 4 new variants]

Insights

This study identified Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in 900 individuals, detecting 24 males and 16 females with the condition. Four novel G6PD variants were discovered during this population survey.

Area of Science:

  • Medical Genetics
  • Biochemistry
  • Paediatrics

Context:

  • Population screening for G6PD deficiency in Genoa, Italy.
  • Focus on paediatric patient cohorts.
  • Investigating genetic variations in a specific demographic.

Purpose:

  • To determine the prevalence of G6PD deficiency.
  • To identify and characterize novel variants of G6PD.
  • To contribute to the understanding of G6PD genetic diversity.

Summary:

  • Screened 900 subjects for G6PD deficiency.
  • Detected 24 G6PD deficient males and 16 females (15 heterozygous, 1 homozygous).
  • Identified and fully characterized four unique, previously unreported G6PD variants.

Impact:

  • Adds to the global knowledge base of G6PD deficiency prevalence.
  • Provides new genetic variants for further research into enzyme function and disease mechanisms.
  • Highlights the importance of genetic screening in paediatric populations.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...